Serina Therapeutics
SER
25 hedge funds and large institutions have $2.86M invested in Serina Therapeutics in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
248% more capital invested
Capital invested by funds: $822K → $2.86M (+$2.03M)
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
14% more funds holding
Funds holding: 22 → 25 (+3)
7.93% more ownership
Funds ownership: 4.03% → 11.96% (+7.9%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$2.2M |
| 2 |
BlackRock
New York
|
+$90.3K |
| 3 |
Jane Street
New York
|
+$87.3K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$76.1K |
| 5 |
AWE
Avidian Wealth Enterprises
Houston,
Texas
|
+$41.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadwood Capital
New York
|
-$104K |
| 2 |
LW
Linscomb Wealth
Houston,
Texas
|
-$36K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$26.9K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$22.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$942 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BC
26
Broadwood Capital
New York
| – | -$104K | -54,484 | Closed |
|
|
LW
27
Linscomb Wealth
Houston,
Texas
| – | -$36K | -18,800 | Closed |
|
|
28
Northern Trust
Chicago,
Illinois
| – | -$26.9K | -14,082 | Closed |
|
|
29
HighTower Advisors
Chicago,
Illinois
| – | -$22.9K | -11,980 | Closed |
|
30
Bank of America
Charlotte,
North Carolina
| – | -$6 | -3 | Closed |
|
SER Hedge Fund Activity: Q1 2026 in Review
25 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Serina Therapeutics (SER) for Q1 2026, worth a combined $2.86M — up 248% from $822K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new SER positions and 5 closed out — a net gain of 5 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Sio Capital Management, opening a new position worth an estimated $2.2M. The largest seller was Broadwood Capital, exiting entirely with an estimated $104K sold.
- 25 institutional investors held Serina Therapeutics (SER) as of Q1 2026, up from 22 in Q4 2025.
- Funds reported $2.86M of Serina Therapeutics stock for Q1 2026, up 248% quarter-over-quarter.
- 10 funds opened new Serina Therapeutics positions in Q1 2026 and 5 closed out, a net change of +5 holders.
- The largest Serina Therapeutics buyer in Q1 2026 was Sio Capital Management, an estimated $2.2M added.
- The largest Serina Therapeutics seller in Q1 2026 was Broadwood Capital, an estimated $104K sold.
Based on aggregated 13F filings for Q1 2026.